Bass and Spangenberg file sixth IPR petition, targeting Pharmacyclics
The Coalition for Affordable Drugs has filed another inter partes review petition at the Patent Trial and Appeal Board, in the latest move by Kyle Bass and Erich Spangenberg to target pharmaceutical companies’ patents
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: